Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s stock price rose 4.9% during trading on Tuesday . The stock traded as high as $16.60 and last traded at $16.60. Approximately 664 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 19,786 shares. The stock had previously closed at $15.82.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on TLX. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a "strong-buy" rating in a research report on Tuesday, November 19th. UBS Group started coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They issued a "buy" rating and a $21.00 price target on the stock.
View Our Latest Analysis on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Trading Up 2.4 %
About Telix Pharmaceuticals Limited American Depositary Shares
(
Get Free Report)
Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.
Featured Articles
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
